Parasite immunomodulatory role in reducing the prevalence of COVID-19 in endemic regions
Nearly 35 million cases and one million deaths over the nine months of the COVID-19 pandemic have been reported worldwide. Africa and some countries with endemic parasitic infections had a low incidence of COVID-19. By contrast, the United States and several European countries, having a non-endemic...
Main Authors: | Bagus Hermansyah, Dini Agustina, Siti Zulaikha, Ali Habibi |
---|---|
Format: | Article |
Language: | English |
Published: |
Faculty of Medicine Trisakti University
2022-04-01
|
Series: | Universa Medicina |
Subjects: | |
Online Access: | https://univmed.org/ejurnal/index.php/medicina/article/view/1212 |
Similar Items
-
The Functioning of Strategic Management in the Control of Endemic Parasitic Diseases in Iran (Case: fascioliasis)
by: Bahador Hajimohammadi, et al.
Published: (2018-03-01) -
Parasitomimetics: Can We Utilize Parasite-Derived Immunomodulatory Molecules for Interventions to Immunological Disorders?
by: Kazuki Nagai, et al.
Published: (2022-03-01) -
Helminth fauna parasitizing Pimelodus pohli (Actinopterygii: Pimelodidae) from the upper São Francisco River, Brazil
by: Claudia Silveira São Sabas, et al. -
Survey of prevalence of intestinal parasites in under hemodialysis patients referred to Sari and Zanjan hospitals, Iran
by: Salman Ghaffari, et al.
Published: (2022-03-01) -
Epidemiology of Canine Visceral Leishmaniasis in the municipality of Taquarana – AL (2009 – 2018) / Epidemiologia da Leishmaniose Visceral Canina no município de Taquarana – AL (2009-2018)
by: Jecilãine Efigênia da Silva, et al.
Published: (2019-05-01)